ES464275A1 - Procedimiento de obtencion de una composicion farmaceutica nasal o pulmonar a base de alcaloides peptidos del corne- zuelo del centeno. - Google Patents

Procedimiento de obtencion de una composicion farmaceutica nasal o pulmonar a base de alcaloides peptidos del corne- zuelo del centeno.

Info

Publication number
ES464275A1
ES464275A1 ES464275A ES464275A ES464275A1 ES 464275 A1 ES464275 A1 ES 464275A1 ES 464275 A ES464275 A ES 464275A ES 464275 A ES464275 A ES 464275A ES 464275 A1 ES464275 A1 ES 464275A1
Authority
ES
Spain
Prior art keywords
hydrogen
nasal mucosa
nasal
peptide alkaloids
ergot peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES464275A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of ES464275A1 publication Critical patent/ES464275A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01D—MEASURING NOT SPECIALLY ADAPTED FOR A SPECIFIC VARIABLE; ARRANGEMENTS FOR MEASURING TWO OR MORE VARIABLES NOT COVERED IN A SINGLE OTHER SUBCLASS; TARIFF METERING APPARATUS; MEASURING OR TESTING NOT OTHERWISE PROVIDED FOR
    • G01D2207/00—Indexing scheme relating to details of indicating measuring values
    • G01D2207/10—Displays which are primarily used in aircraft or display aircraft-specific information

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Procedimiento de obtención de una composición farmacéutica nasal o pulmonar a base de alcaloides péptidos del cornezuelo del centeno, caracterizado porque se asocia, como agente activo, por lo menos un compuesto de fórmula I **(Fórmula)** En donde R1 es hidrógeno o halógeno, R2 es hidrógeno o alquilo de 1 a 4 átomos de carbono, (i) R3 es isopropilo, butilo sec. o isobutilo, R4 es metilo, etilo o isopropilo, y R5 es hidrógeno y R6 es hidrógeno o metoxi, o R5 y R6, juntas, son un enlace simple, o (ii) R3 es bencilo, R4 es metilo, R5 es hidrógeno y R6 es hidrógeno o metoxi, con un diluyente o soporte farmacéuticamente aceptable, adaptado para administración nasal o pulmonar.
ES464275A 1976-11-19 1977-11-18 Procedimiento de obtencion de una composicion farmaceutica nasal o pulmonar a base de alcaloides peptidos del corne- zuelo del centeno. Expired ES464275A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1457576 1976-11-19
CH698977 1977-06-07

Publications (1)

Publication Number Publication Date
ES464275A1 true ES464275A1 (es) 1978-12-16

Family

ID=25700540

Family Applications (1)

Application Number Title Priority Date Filing Date
ES464275A Expired ES464275A1 (es) 1976-11-19 1977-11-18 Procedimiento de obtencion de una composicion farmaceutica nasal o pulmonar a base de alcaloides peptidos del corne- zuelo del centeno.

Country Status (27)

Country Link
US (2) US4462983A (es)
JP (1) JPS5366440A (es)
AT (1) AT368881B (es)
AU (1) AU520754B2 (es)
CA (1) CA1103585A (es)
CS (2) CS228523B2 (es)
CY (1) CY1266A (es)
DE (2) DE2750090A1 (es)
DK (1) DK153440C (es)
ES (1) ES464275A1 (es)
FI (1) FI773376A (es)
FR (1) FR2371454A1 (es)
GB (1) GB1592563A (es)
GR (1) GR65229B (es)
HK (1) HK85984A (es)
HU (1) HU185924B (es)
IE (1) IE46167B1 (es)
IL (1) IL53419A (es)
KE (1) KE3453A (es)
MY (1) MY8400055A (es)
NL (1) NL187892C (es)
NO (1) NO773839L (es)
NZ (1) NZ185711A (es)
PH (1) PH23643A (es)
PT (1) PT67292B (es)
SE (1) SE451944B (es)
SG (1) SG61784G (es)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2750090A1 (de) * 1976-11-19 1978-06-01 Sandoz Ag Neue verabreichungsformen fuer organische verbindungen
US4284648A (en) * 1979-08-03 1981-08-18 The University Of Kentucky Research Foundation Nasal administration of propranolol
CH649300A5 (de) * 1981-08-07 1985-05-15 Sandoz Ag Ergopeptinderivate, ihre herstellung und verwendung.
FI81258C (fi) * 1982-02-01 1990-10-10 Sandoz Ag Foerfarande foer framstaellning av en farmaceutisk komposition foer nasal administration.
GB8301659D0 (en) * 1983-01-21 1983-02-23 Leo Ab Smoking substitutes
GB8413795D0 (en) * 1984-05-30 1984-07-04 Sandoz Ltd Organic compounds
GB8426922D0 (en) * 1984-10-24 1984-11-28 Sandoz Ltd Galenic formulation
GB8501015D0 (en) * 1985-01-16 1985-02-20 Riker Laboratories Inc Drug
FR2628638B1 (fr) * 1985-03-06 1992-12-18 Sandoz Lab Dispositif de pulverisation par voie nasale d'une dose unitaire de medicament en solution
JPS61263918A (ja) * 1985-05-16 1986-11-21 Banyu Pharmaceut Co Ltd 経皮吸収用製剤
AU587472B2 (en) * 1985-05-22 1989-08-17 Liposome Technology, Inc. Liposome inhalation method and system
CA1291036C (en) * 1986-04-23 1991-10-22 Edwin I. Stoltz Nasal administration of drugs
US4782047A (en) * 1986-05-22 1988-11-01 Syntex Pharmaceuticals International Ltd. Aqueous steroid formulations for nasal administration
US4897256A (en) * 1986-11-25 1990-01-30 Abbott Laboratories LHRH analog formulations
DE3710216A1 (de) * 1987-03-27 1988-10-06 Rentschler Arzneimittel Verwendung von dihydroergotamin und seinen salzen zur lokalen behandlung trophischer stoerungen
DE68915203T2 (de) * 1988-03-22 1994-09-22 Fisons Plc, Ipswich, Suffolk Pharmazeutische Mischungen.
US4929640A (en) * 1988-04-04 1990-05-29 George D. McAdory Medicaments intended for combined use in the improvement of lymphocyte function
GB2237510B (en) * 1989-11-04 1993-09-15 Danbiosyst Uk Small particle drug compositions for nasal administration
IT1247472B (it) * 1991-05-31 1994-12-17 Fidia Spa Processo per la preparazione di microsfere contenenti componenti biologicamente attivi.
ES2177544T3 (es) * 1992-06-12 2002-12-16 Teijin Ltd Polvo ultrafinno para inhalar y metodo para su preparacion.
WO1993025193A1 (en) * 1992-06-12 1993-12-23 Teijin Limited Pharmaceutical preparation for intra-airway administration
ES2194867T3 (es) * 1993-03-26 2003-12-01 Franciscus Wilhelmus He Merkus Composiciones farmaceuticas para la administracion intranasal de apomorfina.
US5830853A (en) 1994-06-23 1998-11-03 Astra Aktiebolag Systemic administration of a therapeutic preparation
US20010003739A1 (en) * 1993-06-24 2001-06-14 Astrazeneca Ab Systemic administration of a therapeutic preparation
US6632456B1 (en) 1993-06-24 2003-10-14 Astrazeneca Ab Compositions for inhalation
US6794357B1 (en) 1993-06-24 2004-09-21 Astrazeneca Ab Compositions for inhalation
ES2197212T3 (es) * 1994-12-22 2004-01-01 Astrazeneca Ab Preparacion terapeutica para inhalacion que contiene la hormona paratiroidea, pth.
SE9404468D0 (sv) * 1994-12-22 1994-12-22 Astra Ab Powder formulations
EE9700138A (et) 1994-12-22 1997-12-15 Astra Aktiebolag Aerosoolravimvormid
US6524557B1 (en) * 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
US5955098A (en) * 1996-04-12 1999-09-21 Flemington Pharmaceutical Corp. Buccal non polar spray or capsule
US7771746B2 (en) * 1999-12-03 2010-08-10 Polichem Sa Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
MXPA02007052A (es) * 2000-01-20 2002-12-13 Basilea Pharmaceutica Ag Composiciones que se administran nasalmente y que contienen peptidos ciclicos.
US20030008005A1 (en) * 2001-07-05 2003-01-09 R.T. Alamo Ventures, Inc. Sublingual administration of dihydroergotamine for the treatment of migraine
GB0208742D0 (en) * 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
GB2405334B (en) * 2002-04-17 2006-02-15 Nektar Therapeutics Uk Ltd Particulate materials
ES2691033T3 (es) 2007-02-11 2018-11-23 Map Pharmaceuticals Inc. Método de administración terapéutica de DHE para activar el alivio rápido de la migraña a la vez que se reduce al mínimo el perfil de los efectos secundarios
US20120000941A1 (en) * 2010-06-30 2012-01-05 Inspire Pharmaceuticals, Inc. Medicine dispenser
NZ741171A (en) 2015-09-10 2022-01-28 Impel Neuropharma Inc In-line nasal delivery device
EP3648738A1 (en) * 2017-07-02 2020-05-13 Dr. Reddy's Laboratories Limited Nasal dosage forms of dihydroergotamine
CN111936140A (zh) 2018-01-05 2020-11-13 英倍尔药业股份有限公司 通过精密鼻装置的双氢麦角胺的鼻内递送
EP3893877A4 (en) 2018-12-11 2022-09-14 Satsuma Pharmaceuticals, Inc. COMPOSITIONS, DEVICES AND METHODS FOR TREATMENT OR PREVENTION OF HEADACHE
GB2581431A (en) * 2018-12-11 2020-08-19 Satsuma Pharmaceuticals Inc Compositions, devices, and methods for treating or preventing headaches

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1063512A (en) * 1962-11-30 1967-03-30 Benger Lab Ltd Aerosols
GB1175430A (en) * 1966-04-07 1969-12-23 Sandoz Ltd Pharmaceutical Compositions containing Ergot Alkaloids
CH507249A (de) * 1968-05-31 1971-05-15 Sandoz Ag Verfahren zur Herstellung von 2-Brom-a-ergokryptin
CH534683A (de) * 1970-05-26 1973-03-15 Sandoz Ag Verfahren zur Herstellung neuer Mutterkornpeptidalkaloide
US4076715A (en) * 1972-09-26 1978-02-28 Sandoz Ltd. 13-Bromo lysergic acid compounds
CA990287A (en) * 1972-09-26 1976-06-01 Sandoz Patents Limited 13-bromo-lysergic acid compounds
NL7314066A (es) * 1972-10-18 1974-04-22
US3896228A (en) * 1973-03-15 1975-07-22 Sandoz Ltd Method for treating nephrises
US3883655A (en) * 1973-10-11 1975-05-13 Sandoz Ltd Ergocornine or 2-bromo-{60 -ergocyptine in the treatment of parkinsonism
DE2750090A1 (de) * 1976-11-19 1978-06-01 Sandoz Ag Neue verabreichungsformen fuer organische verbindungen
EP0119493A1 (en) * 1983-03-16 1984-09-26 American Cyanamid Company Use of copolymers of 2-acrylamido-2-methylpropane sulfonic acid for improving retention and dewatering in the manufacture of paper

Also Published As

Publication number Publication date
DE2802113A1 (de) 1979-07-26
JPS5366440A (en) 1978-06-13
AU3078377A (en) 1979-05-24
FR2371454B1 (es) 1980-08-22
ATA825477A (de) 1982-04-15
HU185924B (en) 1985-03-28
SG61784G (en) 1985-03-15
FI773376A (fi) 1978-05-20
US4758423A (en) 1988-07-19
IE46167B1 (en) 1983-03-09
NO773839L (no) 1978-05-22
IL53419A0 (en) 1978-01-31
FR2371454A1 (fr) 1978-06-16
US4462983A (en) 1984-07-31
PT67292B (fr) 1979-11-12
SE7712693L (sv) 1978-05-20
DK153440B (da) 1988-07-18
PH23643A (en) 1989-09-27
JPS6313965B2 (es) 1988-03-29
CS228523B2 (en) 1984-05-14
NL7712552A (nl) 1978-05-23
KE3453A (en) 1984-10-05
IL53419A (en) 1982-04-30
AU520754B2 (en) 1982-02-25
AT368881B (de) 1982-11-25
HK85984A (en) 1984-11-16
NL187892C (nl) 1992-02-17
CS228502B2 (en) 1984-04-16
PT67292A (fr) 1977-12-01
NL187892B (nl) 1991-09-16
SE451944B (sv) 1987-11-09
DK499477A (da) 1978-05-20
DE2750090A1 (de) 1978-06-01
CA1103585A (en) 1981-06-23
GB1592563A (en) 1981-07-08
MY8400055A (en) 1984-12-31
DK153440C (da) 1989-01-02
IE46167L (en) 1978-05-19
GR65229B (en) 1980-07-30
NZ185711A (en) 1980-04-28
CY1266A (en) 1984-11-23

Similar Documents

Publication Publication Date Title
ES464275A1 (es) Procedimiento de obtencion de una composicion farmaceutica nasal o pulmonar a base de alcaloides peptidos del corne- zuelo del centeno.
NO891082D0 (no) Fremgangsmaate for fremstilling av peptidforbindelser.
DE3271269D1 (en) Benzimidazole derivatives, process for the preparation thereof and pharmaceutical composition containing the same
ES8107185A1 (es) Procedimiento para preparar piperidinas y pirrolidinas sus- tituidas
NO153455C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive, substituerte imidazolderivater.
NO163569C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 6-thioxanthinderivater.
ES8401961A1 (es) Procedimiento para la preparacion de nuevas n-(4-indolil-piperidino-alcohil-bencimidazolonas sustituidas.
NO155884C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazol-derivater.
IE800327L (en) N-substituted aziridine-2-carboxylic acid derivatives
JPS5759894A (en) Cephalosporin for oral administration
NO158017C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolderivater.
ES8304567A1 (es) "un procedimiento para preparar nuevos derivados de la n-dihidrotiazolil-3-quinolein-carboxamida".
ES8800145A1 (es) Un procedimiento para preparar un derivado de semicarbazida
ES8404360A1 (es) Un procedimiento para preparar compuestos de cefem.
ES8601915A1 (es) Un procedimiento para preparar derivados de piridazinona
IE42763L (en) Tertiary amino alkylphenyl ether compounds, anesthetics
ES8606880A1 (es) Un procedimiento para la preparacion de nuevos peptidos.
ES8205770A1 (es) Procedimiento para la preparacion de derivados de 2,3-indo- lediona
GB1494560A (en) 4-aryl-5-aminoalkyl-4-thiazolin-2-ones and their preparation
GB1519210A (en) Antiarrythmic compositions containing pyrrolidinyl derivatives
GB990887A (en) Carbamic acid derivatives
IE811212L (en) Substituted phenoxy-aminopropanol derivatives
ES8801652A1 (es) Un procedimiento para la preparacion de un derivado de tiazolidina.
GB1505859A (en) Azetidinone derivatives
FI860997A0 (fi) Bensen-fusionerad heterocyklisk foerening.

Legal Events

Date Code Title Description
PC1A Transfer granted